October Release - 10/04/2021
For additional information about RxNorm releases, including scripts for loading the RxNorm data into Oracle and MySQL databases, read the RxNorm Technical Documentation.
Sources
The following sources with version names in bold have been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Vaccines Administered | CVX | CVX_2021_09_15 |
| DrugBank | DRUGBANK | DRUGBANK5.0_2021_09_03 |
| Gold Standard Drug Database | GS | GS_2021_09_08 |
| Multum MediSource Lexicon | MMSL | MMSL_2021_09_01 |
| Micromedex RED BOOK | MMX | MMX_2021_09_12 |
| FDA Structured Product Labels | MTHSPL | MTHSPL_2021_09_24 |
| FDB MedKnowledge (formerly NDDF Plus) | NDDF | NDDF_2021_09_08 |
| RxNorm normalized names and codes | RXNORM | RXNORM_20AA_211004F |
| Veterans Health Administration National Drug File | VANDF | VANDF_2021_08_31 |
The following sources have not been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Anatomical Therapeutic Chemical Classification System | ATC | ATC_2021 |
| Medical Subject Headings (MeSH) | MSH | MSH2021_2021_01_25 |
| CMS Formulary Reference File | MTHCMSFRF | MTHCMSFRF_2020 |
| US Edition of SNOMED CT (drug information) | SNOMEDCT_US | SNOMEDCT_US_2021_07_31 |
| USP Compendial Nomenclature | USP | USP_2021_07_15 |
*Reminder: As of October 2017, Medi-Span data will not be included in the RxNorm or UMLS releases. If you have questions about Medi-Span, please contact: medispan-support@wolterskluwer.com.
RXNORM DATA CHANGES
No major changes
RELATED NEWS
FDA Approves First COVID-19 Vaccine
Pfizer received FDA biologics license application (BLA) approval on August 23, 2021 for its COVID-19 vaccine for use in individuals 16 and older, which will now be marketed as COMIRNATY. At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename.
At present, Pfizer does not plan to produce any product with these new NDCs and labels over the next few months while the emergency use authorized (EUA) product is still available and being made available for U.S. distribution. As such, the CDC, AMA, and drug compendia may not publish these new codes until Pfizer has determined when the product will be produced with the BLA labels.
Data Counts
| Term Type or Attribute | Number |
|---|---|
| Active GPCKs | 454 |
| Active BPCKs | 532 |
| Active SCDs | 17155 |
| Active SBDs | 9514 |
| Active RXNORM MINs | 3764 |
| Active RXNORM INs | 13534 |
| Active RXNORM PINs | 3144 |
| Active RXNORM BNs | 5162 |
| Active RXNORM DFs | 121 |
| Obsolete GPCKs | 242 |
| Obsolete BPCKs | 208 |
| Obsolete SCDs | 18444 |
| Obsolete SBDs | 10903 |
| Obsolete RXNORM MINs | 0 |
| Obsolete RXNORM INs | 0 |
| Obsolete RXNORM PINs | 0 |
| Obsolete RXNORM BNs | 6148 |
| Obsolete RXNORM DFs | 63 |
| Editor-suppressed SCDs | 1846 |
| Editor-suppressed SBDs | 1522 |
| SAB=RXNORM NDCs | 256836 |
| Distinct SAB=RXNORM NDCs | 256836 |
Last Reviewed: October 4, 2021